[HTML][HTML] Factors affecting buprenorphine utilization and spending in Medicaid, 2002-2018
RE Barenie, MS Sinha, AS Kesselheim - Value in Health, 2021 - Elsevier
Objective Buprenorphine is an essential medication for the treatment of opioid use disorder
(OUD), but studies show it has been underused over the last 2 decades. We sought to …
(OUD), but studies show it has been underused over the last 2 decades. We sought to …
Pronounced State-Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019–2020)
Objective: The purpose of this study was to analyze buprenorphine prescribing across states
in Medicaid patients during 2019–2020. Method: Buprenorphine prescriptions per Medicaid …
in Medicaid patients during 2019–2020. Method: Buprenorphine prescriptions per Medicaid …
National trends in buprenorphine treatment for opioid use disorder from 2007 to 2018
Background: Buprenorphine is a key medication to treat opioid use disorder (OUD). Since its
approval in 2002, buprenorphine access has grown markedly, spurred by major federal and …
approval in 2002, buprenorphine access has grown markedly, spurred by major federal and …
Trends in out-of-pocket costs for and characteristics of pharmacy-dispensed buprenorphine medications for opioid use disorder treatment by type of payer, 2015 to …
AE Strahan, S Desai, K Zhang, GP Guy - JAMA Network Open, 2023 - jamanetwork.com
Importance Buprenorphine has been approved for opioid use disorder treatment, yet
remains underutilized. Cost may present a barrier; little is known about how out-of-pocket …
remains underutilized. Cost may present a barrier; little is known about how out-of-pocket …
Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic Entry.
OBJECTIVES: To investigate trends in Medicare coverage of buprenorphine-naloxone film
before and after the FDA approval of its first generic versions. STUDY DESIGN: This study …
before and after the FDA approval of its first generic versions. STUDY DESIGN: This study …
Buprenorphine treatment for opioid use disorder: comparison of insurance restrictions, 2017–21: study examines insurance restrictions on buprenorphine treatment for …
Buprenorphine is a treatment medication that decreases mortality risks among people with
opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …
opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …
Trends in buprenorphine to treat opioid use disorder in California, 2012 to 2018: Medicaid outpaces the rest of the state
IE Tseregounis, JJ Gasper… - Journal of addiction …, 2021 - journals.lww.com
Objectives: Opioid use disorder remains undertreated in the United States. One of the
primary mechanisms for expanding access to treatment has been the use of buprenorphine …
primary mechanisms for expanding access to treatment has been the use of buprenorphine …
Economic evaluation of extended-release buprenorphine for persons with opioid use disorder
JM Flam-Ross, E Marsh, M Weitz… - JAMA Network …, 2023 - jamanetwork.com
Importance In 2017, the US Food and Drug Administration (FDA) approved a monthly
injectable form of buprenorphine, extended-release buprenorphine; published data show …
injectable form of buprenorphine, extended-release buprenorphine; published data show …
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States
Objectives: The buprenorphine/naloxone combination for the treatment of opioid
dependence is available in a film or tablet formulation. Recent retrospective studies …
dependence is available in a film or tablet formulation. Recent retrospective studies …
An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases
ZS Hsu, JA Warnick, TR Harkins… - Pharmacology …, 2023 - Wiley Online Library
Opioid overdose remains a problem in the United States despite pharmacotherapies, such
as buprenorphine, in the treatment of opioid use disorder. This study characterized changes …
as buprenorphine, in the treatment of opioid use disorder. This study characterized changes …